Oral cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 437: Line 437:
|Non-Hodgkin lymphoma
|Non-Hodgkin lymphoma
|
|
|Second  most  com-
mon  cancer  of  the  oral  cavity.
|
|
* There  is  no  known  etiology  in  most patients.
* Underlying  immunodeficiency  state  (e.g.  HIV Infection)
* Strong association with EBV
|
|
|
|
* Palate,
* Tongue
* Floor  of  mouth
* Gingiva
* Buccal mucosa
* Lips
* Palatine tonsils
* Lingual tonsils or
* Oropharynx
|NHL  of  the  lip presents with:
* Ulcer
* Swelling,
* Discoloration
* Pain
* Paraesthesia
* Anaesthesia,  or
* Loose  teeth
|
|
|
 
|
Biopsy shows:
* Large cells with predominantly round nuclei and membrane-bound nucleoli, consistent with centroblastic morphology.
 
* Predominantly medium-sized cells with abundant pale cytoplasm.
* Large cells with round or multilobated nuclei
|-
|-
|Extramedullary plasmacytoma
|Extramedullary plasmacytoma
|
|9734/3
|
|
|
|
Line 454: Line 484:
|-
|-
|Langerhans cell histiocytosis
|Langerhans cell histiocytosis
|9751/1
|
|
|Associated with:
* Eosinophilic  granulomas
* Multifocal  multisystem  disease
|
|
|
|
|
* Jaw  bone
|
* Intraoral soft tissues
|
* Gingiva
|
 
* Palate
* Floor  of  mouth
* Buccal  mucosa
and 
* Tonsil
|Common  oral  symptoms
 
include:
* Swelling
* Pain
* Gingivitis
* Loose teeth  and
* Ulceration
|Biopsy shows ovoid  Langerhans  cells
 
with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm
|-
|-
|Hodgkin lymphoma
|Hodgkin lymphoma
|
|
|
|
|Strongly associated with Epstein- Barr Virus
|
|
|
|
|
* Waldeyer  ring,  particularly  the  pala-tine tonsil
|
* Oropharynx 
* Alveolar  crest  of  mandible
* Maxillary  gingiva
|Most patients present with localized disease (stage I/II), with
* Chronic tonsillitis or tonsillar enlargement with or  without  enlarged  cervical  lymph nodes
|
|
|-
|-
|Extramedullary myeloid
|Extramedullary myeloid
sarcoma
sarcoma
|9930/3
|
|
|History of acute  myeloid  leukaemia,
predominantly  in  the  monocytic  or
myelomonocytic      subtypes
|
|
|
|
|
* Palate
|
 
|
* Gingiva
|
|Isolated tumor-forming intraoral mass
|Biopsy shows an Indian-file pattern of infiltration
|-
|-
|Follicular dendritic cell
|Follicular dendritic cell
sarcoma / tumour
sarcoma / tumour
|9758/3
|
|
* Tumor of adulthood
* Affects wide age range
|History of underlying hya-line-vascular Castleman disease
|
|
|
|
|
* Tonsil
|
* Palate or
|
* Oropharynx.
|
|The  patients  usually
 
present  with  a  painless  mass
|Biopsy usually  exhibits
 
borders and comprises:
* Fascicles
* Whorls
 
* Nodules, 
 
* Storiform  arrays  or 
* Diffuse sheets  of  spindly  to  ovoid  tumour  cells sprinkled  with  small  lymphocytes
|-
|-
|Mucosal malignant melanoma
|Mucosal malignant melanoma
|
|
|8720/3
|
|
* 0.5%  of  oral  malignancies
* Incidence 0.02 per 100,000
|No known etiological  factors associated with oral melanoma
|
|
|80%  arise:
* Palate
* Maxillary alveolus or gingivae
* Mandibular
gingivae
Others:
* Buccal mucosa
* Floor of mouth
* Tongue
|
|
* Asymmetric with  irregular  outlines
* Macular  pigmentation
* Nodular growth
* Ulceration 
* Melanosis
|
|
|
* Biopsy:
|
* S100  positive
|
* Negative  for  cytokeratins 
|-
 
|
* More  specific  markers  include:
|
* HMB45,
|
 
|
* Melan-A  or  anti-tyrosinase
|
|
|
|
|
|-
|
|
|
|
|
|
|
|
|
|}
|}



Revision as of 19:15, 5 February 2018

Oral cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oral cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oral cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oral cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oral cancer differential diagnosis

CDC on Oral cancer differential diagnosis

Oral cancer differential diagnosis in the news

Blogs on Oral cancer differential diagnosis

Directions to Hospitals Treating Oral cancer

Risk calculators and risk factors for Oral cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

There are different types of cancers of the oral cavity and oropharynx. It is important that they are differentiated from one another.

Oral cancer must be differentiated from actinic keratosis, dermatologic manifestations of oral leukoplakia, erythroplasia, lichen planus and mucosal candidiasis.

Oral cancer differential diagnosis

Type of cancer Subtype ICD-O Code Epidemiology Etiology Second primary tumors Localization Clinical features Diagnostic procedures
Squamous cell carcinoma Verrucous carcinoma 8051/3 Older males
  • Chronic smokeless tobacco
  • HPV 16 and 18
Basaloid squamous cell carcinoma 8083/3
Papillary squamous cell carcinoma 8052/3
Spindle cell carcinoma 8074/3
Acantholytic squamous cell carcinoma 8075/3
Adenosquamous carcinoma 8560/3
Carcinoma cuniculatum

(epithelioma cuniculatum)

8051/3
Lymphoepithelial carcinoma
Epithelial precursor lesions
Proliferative verrucous leukoplakia and precancerous conditions
Papillomas Squamous cell papilloma and

verruca vulgaris

Condyloma acuminatum
Papillomas and papillomatosis

in immunodeficiency

Focal epithelial hyperplasia
Granular cell tumour
Keratoacanthoma
Papillary hyperplasia
Median rhomboid glossitis
Median rhomboid glossitis
Salivary gland tumours Acinic cell carcinoma 8550/3
Mucoepidermoid carcinoma 8430/3
Adenoid cystic carcinoma 8200/3
Polymorphous low-grade

adenocarcinoma

8525/3
Epithelial-myoepithelial

carcinoma

8562/3
Clear cell carcinoma,

NOS

8310/3
Basal cell

adenocarcinoma

8147/3
Cystadenocarcinoma 8450/3
Mucinous adenocarcinoma 8480/3
Oncocytic carcinoma 8290/3
Salivary duct carcinoma 8500/3
Myoepithelial carcinoma 8982/3
Carcinoma ex pleomorphic

adenoma

8941/3
Salivary gland adenomas Pleomorphic adenoma 8940/0
Myoepithelioma 8982/0
Basal cell adenoma 8147/0
Canalicular adenoma 8149/0
Duct papilloma 8503/0
Cystadenoma 8440/0
Kaposi sarcoma
Lymphangioma
Ectomesenchymal chondromyxoid

tumour of the anterior tongue

Focal oral mucinosis
Congenital granular cell epulis
Haematolymphoid tumours Non-Hodgkin lymphoma Second most com-

mon cancer of the oral cavity.

  • There is no known etiology in most patients.
  • Underlying immunodeficiency state (e.g. HIV Infection)
  • Strong association with EBV
  • Palate,
  • Tongue
  • Floor of mouth
  • Gingiva
  • Buccal mucosa
  • Lips
  • Palatine tonsils
  • Lingual tonsils or
  • Oropharynx
NHL of the lip presents with:
  • Ulcer
  • Swelling,
  • Discoloration
  • Pain
  • Paraesthesia
  • Anaesthesia, or
  • Loose teeth

Biopsy shows:

  • Large cells with predominantly round nuclei and membrane-bound nucleoli, consistent with centroblastic morphology.
  • Predominantly medium-sized cells with abundant pale cytoplasm.
  • Large cells with round or multilobated nuclei
Extramedullary plasmacytoma 9734/3
Langerhans cell histiocytosis 9751/1 Associated with:
  • Eosinophilic granulomas
  • Multifocal multisystem disease
  • Jaw bone
  • Intraoral soft tissues
  • Gingiva
  • Palate
  • Floor of mouth
  • Buccal mucosa

and

  • Tonsil
Common oral symptoms

include:

  • Swelling
  • Pain
  • Gingivitis
  • Loose teeth and
  • Ulceration
Biopsy shows ovoid Langerhans cells

with deeply grooved nuclei, thin nuclear membranes and abundant eosinophilic cytoplasm

Hodgkin lymphoma Strongly associated with Epstein- Barr Virus
  • Waldeyer ring, particularly the pala-tine tonsil
  • Oropharynx
  • Alveolar crest of mandible
  • Maxillary gingiva
Most patients present with localized disease (stage I/II), with
  • Chronic tonsillitis or tonsillar enlargement with or without enlarged cervical lymph nodes
Extramedullary myeloid

sarcoma

9930/3 History of acute myeloid leukaemia,

predominantly in the monocytic or myelomonocytic subtypes

  • Palate
  • Gingiva
Isolated tumor-forming intraoral mass Biopsy shows an Indian-file pattern of infiltration
Follicular dendritic cell

sarcoma / tumour

9758/3
  • Tumor of adulthood
  • Affects wide age range
History of underlying hya-line-vascular Castleman disease
  • Tonsil
  • Palate or
  • Oropharynx.
The patients usually

present with a painless mass

Biopsy usually exhibits

borders and comprises:

  • Fascicles
  • Whorls
  • Nodules,
  • Storiform arrays or
  • Diffuse sheets of spindly to ovoid tumour cells sprinkled with small lymphocytes
Mucosal malignant melanoma 8720/3
  • 0.5% of oral malignancies
  • Incidence 0.02 per 100,000
No known etiological factors associated with oral melanoma 80% arise:
  • Palate
  • Maxillary alveolus or gingivae
  • Mandibular

gingivae

Others:

  • Buccal mucosa
  • Floor of mouth
  • Tongue
  • Asymmetric with irregular outlines
  • Macular pigmentation
  • Nodular growth
  • Ulceration
  • Melanosis
  • Biopsy:
  • S100 positive
  • Negative for cytokeratins
  • More specific markers include:
  • HMB45,
  • Melan-A or anti-tyrosinase

References


Template:WH Template:WS